v3.26.1
Notes Payable - 2025 March Unsecured SPA Notes Narrative (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
May 28, 2025
$ / shares
Mar. 21, 2025
USD ($)
day
closing
$ / shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
shares
Mar. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
May 15, 2025
$ / shares
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Debt Instrument [Line Items]                      
Exercise price (in dollars per share) | $ / shares     $ 219.60   $ 219.60            
2025 March Unsecured SPA Notes                      
Debt Instrument [Line Items]                      
Debt instrument, term         5 years            
Percent of purchaser's conversion shares     100.00%   100.00%            
2025 March Unsecured SPA Notes                      
Debt Instrument [Line Items]                      
Aggregate principal amount   $ 41,000                  
Debt instrument, number of closings | closing   4                  
Debt instrument, term   5 years                  
Contractual Interest Rates   10.00%                  
Debt instrument, redemption price, percentage   10.00%                  
Redemption price, percentage   25.00%                  
Conversion price (in dollars per share) | $ / shares $ 183.00 $ 193.50                  
Debt instrument, floor price (in dollars per share) | $ / shares     $ 157.200   $ 157.200            
Debt instrument, SPA waiver, term                 45 days    
Debt instrument, SPA waiver, deferral period                 20 days    
Share price (in dollars per share) | $ / shares                 $ 1.00    
Debt instrument, convertible, threshold percentage of stock price trigger 100.00%                    
Debt instrument, exercisable, threshold percentage of stock price trigger 120.00%                    
Exercise price (in dollars per share) | $ / shares $ 219.600                    
2025 March Unsecured SPA Notes | Series B Preferred Stock                      
Debt Instrument [Line Items]                      
Pro rata aggregate cap (in shares) | shares     9,000,000   9,000,000            
Notes Payable                      
Debt Instrument [Line Items]                      
Notes and loans payable     $ 99,928 $ 28,033 $ 99,928 $ 28,033 $ 46,367 $ 60,666   $ 24,674 $ 49,488
Gain (loss) on fair value adjustment of debts     $ 3,045 (8,723) $ (2,167) 13,057          
Notes Payable | 2025 March Unsecured SPA Notes                      
Debt Instrument [Line Items]                      
Debt instrument, term         5 years            
Contractual Interest Rates   18.00% 10.00%   10.00%     10.00%      
Redemption price, percentage   8.00%                  
Debt instrument, convertible, threshold consecutive trading days | day   5                  
Notes and loans payable     $ 3,373 9,297 $ 3,373 9,297 $ 3,442 $ 2,108   $ 763 $ 0
Proceeds from debt, net of issuance costs     0 22,100 4,700 24,100          
Debt conversion, converted amount     $ 0 $ 6,800 $ 1,700 $ 6,800          
Shares issued from conversion (in shares) | shares     0 41,131 12,252 41,131          
Gain (loss) on extinguishment of debt     $ 0 $ (5,500) $ (1,300) $ (5,500)          
Gain (loss) on fair value adjustment of debts     $ 69 $ (2,757) $ (18) $ (2,713)